News

Join the Excitement at Karmanos' 3rd Classic Cars Event

Join the Excitement at Karmanos' 3rd Classic Cars Event

Exciting Details of Karmanos' 3rd Annual Classic Cars Event

The Barbara Ann Karmanos Cancer Institute is thrilled to announce preparations for the much-anticipated 3rd Annual Classic Cars for the Cure. This unique event promises to be an unforgettable evening celebrating the love for classic automobiles while contributing to vital cancer research.

A Night to Remember

Scheduled for September 20, the Classic Cars for the Cure will bring together friends and car enthusiasts from all over. The event is set to take place in a lavish indoor garage, creating an exclusive atmosphere where attendees can indulge in gourmet delights. Guests will enjoy a delightful strolling dinner expertly crafted by Forte Belanger, complemented by live entertainment with '50s and '60s music, performed by the talented Stella and her band Intrigue.

Celebrating Passion for Cars

The gala isn’t just about dining and music; it’s about celebrating a passion shared by many. Attendees will have the opportunity to view a magnificent collection of rare classic cars. As they explore these vintage beauties, they will hear their compelling stories from collectors, who passionately discuss what makes these cars distinctive.

Mission Behind the Event

Deborah Savoie from Karmanos explains the event's significance: "While we enjoy our love for cars, we're also actively contributing funds needed for local cancer research." This underscores the event's dual purpose: to celebrate classic vehicles and to raise awareness and funds for cancer research initiatives.

Featured Cars and Special Guests

Al Trombetta, a car curator and ardent classic car enthusiast, has pulled together an impressive lineup of 25 rare automobiles from museums and top collectors. His personal connection to the cause, stemming from the loss of his mother to lung cancer, drives his commitment to ensure the event’s success. “Cars have unique personalities, much like people,” Trombetta notes, emphasizing the rich narratives these vehicles carry.

Inspiring Contributions to Cancer Research

Debra Partrich of Karmanos commends Trombetta’s dedication and highlights the collective effort needed to support cancer research. Karmanos provides groundbreaking cancer therapies and champions innovative research. The event will not only highlight extraordinary vehicles but also raise crucial funds to support Karmanos' researchers, who work tirelessly to advance treatment options for patients battling cancer.

Interactive Features and Educational Experience

This year’s event introduces innovative interactive features, including “What’s My Line,” where guests can engage directly with researchers from Karmanos to discuss their pivotal work in cancer research. Key speakers, including Dr. Boris Pasche, who leads Karmanos, will share insights into the latest developments in cancer treatments.

Leading the Charge for Cancer Research

Dr. Pasche’s leadership since joining Karmanos reflects a commitment to excellence in cancer care and research. His team is recognized for their advances in therapies and techniques aimed at improving survivorship. They hope that this event encourages further support and awareness of their mission.

Event Details and Ticket Information

Don’t miss out on this remarkable gathering. The Classic Cars for the Cure will take place on September 20 from 7 to 10:30 PM at 1330 North Crooks Rd. Guests are encouraged to dress in cocktail attire or embrace the flair of the '50s and '60s to enhance the event's theme.

Tickets are available for $250 each and are sure to offer great value considering the wonderful experience awaiting guests. To learn more about the event and secure your tickets, visit karmanos.org/cars25.

Frequently Asked Questions

What is the purpose of the Classic Cars for the Cure event?

The event aims to celebrate classic cars while raising funds for vital cancer research at Karmanos Cancer Institute.

Who can attend the event?

Car enthusiasts, friends, and anyone interested in supporting cancer research are welcome to attend.

What activities can guests expect at the event?

Guests will enjoy live music, gourmet food, an exhibit of rare classic cars, and interactive discussions with researchers.

Where will the event be held?

The event will take place indoors at a private garage location on North Crooks Rd.

How much do tickets cost?

Each ticket is priced at $250, offering a night of entertainment and support for a vital cause.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 20

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 93

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 177

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 135

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 93

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 73

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Magnolia Data Breach: Legal Stakes Loom for Seniors

Updated Category News Views 192

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 23

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 97

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading